Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Constellation Brands
STZ
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
ABVX Abivax S.A.
- 7.080
- +0.240+3.51%
Trading Apr 28 11:47 ET
448.75MMarket Cap-2.23P/E (TTM)
7.139High7.045Low17.31KVolume6.960Open6.840Pre Close122.68KTurnover0.05%Turnover RatioLossP/E (Static)63.38MShares15.06052wk High9.74P/B226.61MFloat Cap4.77052wk Low--Dividend TTM32.01MShs Float17.020Historical High--Div YieldTTM1.38%Amplitude4.770Historical Low7.085Avg Price1Lot Size
About Abivax S.A. Company
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
Company Profile
SymbolABVX
Company NameAbivax S.A.
Issue Price11.60
Founded2013
CEOMr. Marc de Garidel
MarketNASDAQ
Employees69
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address7-11 Boulevard Haussmann
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75009
Phone33-1-53-83-09-63
Websitehttp://www.abivax.com
Company Executives
- Name
- Position
- Salary
- Marc de Garidel
- Chief Executive Officer and Chairman of the Board
- --
- Ida Hatoum
- Chief People Officer
- --
- Sheldon Sloan
- Chief Medical Officer
- --
- Pierre Courteille
- Chief Business Officer
- --
- Michael Ferguson
- Chief Commercial Officer
- --
- Didier Scherrer
- Chief Scientific Officer
- --
- Didier Blondel
- Chief Financial Officer and Secretary of the Board
- --
- Dr. Philippe Pouletty
- Director
- --
- Corinna zur Bonsen-Thomas
- Independent Director
- --
- Camilla Soenderby
- Independent Director
- --
- Troy A. Ignelzi
- Independent Director
- --
- Kinam Hong
- Independent Director
- --
- Dr. June Lee, M.D.
- Independent Director
- --
- Dr. Carol L. Brosgart, M.D.
- Independent Director
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now